{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:12:58Z","timestamp":1792699978158,"version":"4.5.0"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med. Technol."],"abstract":"<jats:p>The sterility assurance community is facing significant challenges. A relatively recent challenge is the pressure on manufacturing supply chains resulting from the limited availability of capacity for terminal sterilization of healthcare products. The current challenge is finding solutions for innovative new products, especially biologics and combination products, that offer great promise for patients around the world. This challenge will become more prevalent in the future as products advance. This article frames new paradigms and tools being developed to address these challenges. Foundational principles and current realities from each sector are reviewed so that sterility assurance professionals have a solid base from which to build strategies.<\/jats:p>","DOI":"10.3389\/fmedt.2021.622710","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T07:15:38Z","timestamp":1628493338000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Sterility Assurance Across-Sectors\u2014New Paradigms and Tools"],"prefix":"10.3389","volume":"3","author":[{"given":"Byron J.","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce M.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trabue D.","family":"Bryans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"B1","volume-title":"Advanced Aseptic Processing Technology","author":"Agalloco","year":"2010"},{"key":"B2","first-page":"39","article-title":"Aseptic processing","volume-title":"Assurance of Sterility for Sensitive Combination -Products Materials, New Paradigms to Bring Innovative Healthcare Products to Patients","author":"Baseman","year":"2019"},{"key":"B3","first-page":"5","article-title":"Chapter 2. Sensitive combination products: Devcies, pharmaceuticals, and biologis","volume-title":"Assurance of Sterility for Sensitive Combination Products Materials, New Paradigms to Bring Innovative Healthcare Products to Patients","author":"Lambert","year":"2019"},{"key":"B4","first-page":"23","article-title":"Terminal sterilization","volume-title":"Assurance of Sterility for Sensitive Combination Products Materials, New Paradigms to Bring Innovative Healthcare Products to Patients","author":"Le","year":"2019"},{"key":"B5","first-page":"156","article-title":"Patient infections: the relevance of sterility assurance levels","volume-title":"Sterilization of Medical Products","author":"Favero","year":"1993"},{"key":"B6","first-page":"110","article-title":"Sterility assurance: concepts for patient safety","volume-title":"Disinfection, Sterilization and Antisepsis: Principles and Practices in Healthcare Facilities.","author":"Favero","year":"2001"},{"key":"B7","first-page":"135","article-title":"Review of current practice in preventing heal care associated infections","volume-title":"Assurance of Sterility for Sensitive Combination Products Materials, New Paradigms to Bring Innovative -Healthcare Products to Patients","author":"Swenson","year":"2019"},{"key":"B8","first-page":"261","article-title":"Post aseptic fill sterilization and lethal treatment","volume-title":"Principles of Parenteral Solution Validation. A Practical Lifecycle Approach","author":"Sadowski","year":"2019"},{"key":"B9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.5731\/pdajpst.2016.007104","article-title":"Increasing patient safety by closing the sterile production gap \u2013 part 1. Introduction","volume":"71","author":"Agalloco","year":"2017","journal-title":"PDA J Pharm Sci Tech"},{"key":"B10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.5731\/pdajpst.2016.007112","article-title":"Increasing patient safety by closing the sterile production gap \u2013 part 2. Implementation","volume":"71","author":"Agalloco","year":"2017","journal-title":"PDA J Pharm Sci Tech"},{"key":"B11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.5731\/pdajpst.2017.007641","article-title":"Increasing patient safety by closing the sterile production gap \u2013 part 3\u2013moist heat resistance of bioburden","volume":"71","author":"Agalloco","year":"2017","journal-title":"PDA J Pharm Sci Tech"},{"key":"B12","first-page":"165","article-title":"Risk to the patient \u2013 quantifying assurance of sterility","volume-title":"Assurance of Sterility for Sensitive Combination Products Materials, New Paradigms to Bring Innovative Healthcare Products to Patients","author":"Speck","year":"2019"},{"key":"B13","first-page":"221","article-title":"Regulatory pathway for labeling combination products as sterile","volume-title":"Assurance of Sterility for Sensitive Combination Products Materials, New Paradigms to Bring Innovative Healthcare Products to Patients.","author":"Bryans","year":"2019"},{"key":"B14","unstructured":"HoxeyE\n          Sterilization \u2013 Regulatory Requirements and Supporting Standards, British Standards Institute, Medical Device White Paper Series2020"},{"key":"B15","first-page":"79","article-title":"Package\/container closures","volume-title":"Assurance of Sterility for Sensitive Combination Products Materials, New Paradigms to Bring Innovative Healthcare Products to Patients","author":"Wagner","year":"2019"}],"container-title":["Frontiers in Medical Technology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmedt.2021.622710\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T07:15:55Z","timestamp":1628493355000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmedt.2021.622710\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":15,"alternative-id":["10.3389\/fmedt.2021.622710"],"URL":"https:\/\/doi.org\/10.3389\/fmedt.2021.622710","relation":{},"ISSN":["2673-3129"],"issn-type":[{"value":"2673-3129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,9]]},"article-number":"622710"}}